TITLE

10. Glucose control: Insulin-based therapies

PUB. DATE
June 2012
SOURCE
Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, pS32
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the use of insulin in treating patients with type 2 diabetes. It cites several studies that provide guidance for the rational use of various insulins in diabetes treatment, and offers recommendations for the initiation of basal insulin and pre-mixed insulin in diabetic patients. Moreover, it explores some requirements for the administration of additional insulin during periods of illness, stress and uncontrolled glucose level.
ACCESSION #
78950848

 

Related Articles

  • Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine. RIDDLE, MATTHEW C.; FORST, THOMAS; ARONSON, RONNIE; SAUQUE-REYNA, LEOBARDO; SOUHAMI, ELISABETH; SILVESTRE, LOUISE; LIN PING; ROSENSTOCK, JULIO // Diabetes Care;Sep2013, Vol. 36 Issue 9, p2497 

    OBJECTIVE--When oral therapy for type 2 diabetes is ineffective, adding basal insulin improves glycemic control. However, when glycated hemoglobin (HbA1c) remains elevated because of postprandial hyperglycemia, the next therapeutic step is controversial. We examined the efficacy and safety of...

  • Insulin glulisine provides improved glycemic control in patients with type 2 diabetes. Dailey, George; Rosenstock, Julio; Moses, Robert G.; Ways, Kirk // Diabetes Care;Oct2004, Vol. 27 Issue 10, p2363 

    Objective: Insulin glulisine is a novel analog of human insulin designed for use as a rapid-acting insulin. This study compared the safety and efficacy of glulisine with regular human insulin (RHI) in combination with NPH insulin.Research Design and Methods: In total,...

  • Glycemic Variability in Patients with Type 2 Diabetes on Basal Insulin and Fixed Combination Oral Antidiabetic Treatment - Results of a Pilot Study. De Mattia, Giancarlo; Laurenti, Oriana; Moretti, Arianna; Mollica, Maria R. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA148 

    Type 2 diabetes (T2DM) is a progressive disease, which may eventually require insulin therapy when glycemic control fails using oral antidiabetic drugs (OADs) alone. Once-daily glargine ensures a 24-hr basal insulin replacement in T2DM patients, which can allow lower glycemic fluctuations during...

  • Treatment of type 2 diabetes. Nazarko, Linda // British Journal of Healthcare Assistants;Mar2010, Vol. 4 Issue 3, p124 

    When a person has been diagnosed with type 2 diabetes, treatment aims to maintain normoglycaemia (blood sugar within normal limits), relieve the symptoms of diabetes, maintain or improve quality of life and prevent the complications associated with diabetes, such as stroke, heart attack, eye and...

  • Insulin Treatment of Fasting or Postprandial Glucose in Type 2 Diabetes. Does It Matter? The South Danish Diabetes Study (SDDS). Henriksen, Jan Erik; Gram, Jeppe; Beck-Nielsen, Henning // Diabetes;Jun2007 Supplement 1, Vol. 56, pA51 

    Insulin treatment of fasting hyperglycaemia using bedtime NPH insulin is often used in Type 2 diabetes whereas treatment of postprandial hyperglycaemia has not gained much impact. This investigator driven, randomised, intention to treat (ITT), and treat to target study compared the effect of NHP...

  • Point: Recent Long-Term Clinical Studies Support an Enhanced Role for Thiazolidinediones in the Management of Type 2 Diabetes. Kahn, Steven E.; Zinman, Bernard // Diabetes Care;Jun2007, Vol. 30 Issue 6, p1672 

    The article presents information on several studies on the role of thiazolidinediones in the management of type 2 diabetes. In 1998, the UK Prospective Diabetes Study (UKPDS) showed that improved glucose control is important in preventing the microvascular complications of diabetes. According to...

  • Approaches to Treatment of Type 2 Diabetes. Bloomgarden, Zachary T. // Diabetes Care;Aug2008, Vol. 31 Issue 8, p1697 

    Information about several papers discussed at the 55th Annual Advanced Postgraduate Course of the American Diabetes Society on treatment of type 2 diabetes held in San Francisco, California on February 1-3, 2008 is presented. Member Ralph DeFronzo said that glimepiride and glipizide reduced...

  • Administration of Miglitol Until 30 Minutes After the Start of a Meal Is Effective in Type 2 Diabetic Patients. Terauchi, Yasuo; Aoki, Kazutaka; Nakamura, Akinobu; Nezu, Uru; Iwasaki, Tomoyuki; Takahashi, Mayumi; Kimura, Mari // Diabetes;Jun2007 Supplement 1, Vol. 56, pA562 

    Pharmacological agents are now available that primarily modify post-prandial plasma glucose levels. The alpha-glucosidase inhibitors (αGIs) represent one such class of agents whose intake is recommended just before a meal; however, adherence to these drugs has been reported to be lower than...

  • Short Insulin Tolerance Test May Determine Thiazolidinediones Treatment in Type 2 Diabetes. Lee, Mi Y.; Koh, Jang H.; Jung, Pil M.; Shim, Myoung S.; Kim, Mi J.; Shin, Jang Y.; Shin, Young G.; Chung, Choon H. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA578 

    The short insulin tolerance test is a simple and reliable method of estimating insulin sensitivity. This study was designed to compare the insulin sensitizing effects of thiazolidinediones (TZDs) on the degree of insulin resistance determined by short insulin tolerance test, Kitt in type 2...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics